Requirement of CD4 T cells for skin graft rejection against thymus leukemia (TL) antigen and multiple epitopes on the TL molecule recognized by CD4 T cells

被引:0
作者
Tsuji, K
Obata, Y
Takahashi, T
Arata, J
Nakayama, E
机构
[1] OKAYAMA UNIV,SCH MED,DEPT PARASITOL & IMMUNOL,OKAYAMA 700,JAPAN
[2] OKAYAMA UNIV,SCH MED,DEPT DERMATOL,OKAYAMA 700,JAPAN
[3] AICHI CANC CTR,RES INST,IMMUNOL LAB,NAGOYA,AICHI,JAPAN
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
By selective depletion of CD4 and CD8 T cells in vivo using the respective mAbs, we demonstrate that CD4 T cells are necessary for skin graft rejection against thymus leukemia (TL) Ag, The skin expressing T3(b)-TL Ag from transgenic C3H Tg.Con.3-1 mice given chimeric H-2K(b)/T3(b)-TL gene was rejected when grafted onto C3H/He recipient mice. Depletion of CD4, but not of CD8, cells blocked rejection, CD8 CTL were generated in MEM (control)-treated C3H/He recipient mice, while Thy-1(+)CD4(-)CD8(-)CTL were generated in CD8-depleted recipient mice after rejection. However, no CTL were generated in CD4-depleted or both CD4- and CD8-depleted recipient mice. Thus, the generation of both CD8 and Thy-1(+)CD4(-)CD8(-) CTL was dependent on CD4 T cells. Ab blocking indicated that both CD8 and Thy-1(+)CD4(-)CD8(-) CTL were TCR alpha beta and recognized TL Ag. We furthermore demonstrated that CD4 T cells in spleen cells from C3H/He mice that had rejected C3H Tg.Con.3-1 skin showed a weak, but significant, proliferative response to in vitro stimulation with mitomycin C-treated C3H Tg.Con.3-1 spleen cells. Analysis of the reactivity of bulk CD4 T cell lines to 73 synthetic overlapping peptides encompassing the entire T3(b)-TL molecule showed that CD4 T cells recognized multiple epitopes on the T3(b)-TL molecule in an APC-dependent manner.
引用
收藏
页码:159 / 166
页数:8
相关论文
共 42 条
[1]   DONOR MAJOR HISTOCOMPATIBILITY COMPLEX (MHC) PEPTIDES ARE PRESENTED BY RECIPIENT MHC MOLECULES DURING GRAFT-REJECTION [J].
BENICHOU, G ;
TAKIZAWA, PA ;
OLSON, CA ;
MCMILLAN, M ;
SERCARZ, EE .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (01) :305-308
[2]  
BOYSE EA, 1963, J NATL CANCER I, V31, P987
[3]   MAP OF THE HUMAN MHC [J].
CAMPBELL, RD ;
TROWSDALE, J .
IMMUNOLOGY TODAY, 1993, 14 (07) :349-352
[4]   TLA-REGION GENES AND THEIR PRODUCTS [J].
CHEN, YT ;
OBATA, Y ;
STOCKERT, E ;
TAKAHASHI, T ;
OLD, LJ .
IMMUNOLOGIC RESEARCH, 1987, 6 (1-2) :30-45
[5]  
DIALYNAS DP, 1983, J IMMUNOL, V131, P2445
[6]   REJECTION OF SKIN ALLOGRAFTS BY INDIRECT ALLORECOGNITION OF DONOR CLASS-I MAJOR HISTOCOMPATIBILITY COMPLEX PEPTIDES [J].
FANGMANN, J ;
DALCHAU, R ;
FABRE, JW .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (06) :1521-1529
[7]  
GAUSEPOHL H, 1990, PEPTIDES CHEM STRUCT, P1003
[8]   T-CELL REQUIREMENTS FOR THE REJECTION OF RENAL-ALLOGRAFTS BEARING AN ISOLATED CLASS-I MHC DISPARITY [J].
GRACIE, JA ;
BOLTON, EM ;
PORTEOUS, C ;
BRADLEY, JA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 172 (06) :1547-1557
[9]   EXPRESSION OF TL-GENES, H-2-GENES AND CHIMERIC H-2/TL-GENES IN TRANSGENIC MICE - ABNORMAL THYMIC DIFFERENTIATION AND T-CELL LYMPHOMAS IN A TL TRANSGENIC STRAIN [J].
HAMASIMA, N ;
TAKAHASHI, T ;
TAGUCHI, O ;
NISHIZUKA, Y ;
STOCKERT, E ;
OLD, LJ ;
OBATA, Y .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (20) :7995-7999
[10]   EXPRESSION OF THE THYMUS LEUKEMIA ANTIGEN IN MOUSE INTESTINAL EPITHELIUM [J].
HERSHBERG, R ;
EGHTESADY, P ;
SYDORA, B ;
BRORSON, K ;
CHEROUTRE, H ;
MODLIN, R ;
KRONENBERG, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (24) :9727-9731